|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q10324505
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241120235821.0 |
|
008
|
|
|
241120nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q10324505
|
|
024
|
|
|
‡a
0000-0003-1613-1235
‡2
orcid
|
|
024
|
|
|
‡a
7101632183
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q10324505
|
|
043
|
|
|
‡c
PT
|
|
046
|
|
|
‡f
19470908
|
|
100
|
0 |
|
‡a
Manuel Sobrinho Simões
‡c
hulumtues
‡9
sq
|
|
375
|
|
|
‡a
1
‡2
iso5218
|
|
400
|
0 |
|
‡a
Manuel Sobrinho Simões
‡c
researcher (ORCID 0000-0003-1613-1235)
‡9
en
|
|
400
|
0 |
|
‡a
Manuel Sobrinho Simões
‡c
Portugees arts
‡9
nl
|
|
400
|
0 |
|
‡a
Manuel Sobrinho Simões
‡c
médico e investigador português
‡9
pt
|
|
400
|
0 |
|
‡a
Manuel Sobrinho Simões
‡c
médicu portugués
‡9
ast
|
|
400
|
0 |
|
‡a
Manuel Sobrinho Simões
‡c
portugiesischer Arzt
‡9
de
|
|
400
|
0 |
|
‡a
Manuel Sobrinho Simões
‡c
ricercatore
‡9
it
|
|
670
|
|
|
‡a
Author's A flow cytometric DNA analysis of medullary thyroid carcinoma
|
|
670
|
|
|
‡a
Author's A follicular variant of papillary thyroid carcinoma in struma ovarii. Case report with unique molecular alterations.
|
|
670
|
|
|
‡a
Author's A founder SDHB mutation in Portuguese paraganglioma patients
|
|
670
|
|
|
‡a
Author's A morphometric study of nuclei, nucleoli and nuclear bodies in goitres and papillary thyroid carcinomas
|
|
670
|
|
|
‡a
Author's A mucin-producing tumor in the thyroid gland
|
|
670
|
|
|
‡a
Author's A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma
|
|
670
|
|
|
‡a
Author's A Polymorphism in the Promoter Region of the Selenoprotein S Gene
|
|
670
|
|
|
‡a
Author's A Polymorphism in the Promoter Region of the Selenoprotein S Gene (SEPS1) Contributes to Hashimoto's Thyroiditis Susceptibility
|
|
670
|
|
|
‡a
Author's A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma
|
|
670
|
|
|
‡a
Author's A scanning and transmission electron microscopic study of human nodular goitre
|
|
670
|
|
|
‡a
Author's A stem cell role for thyroid solid cell nests.
|
|
670
|
|
|
‡a
Author's A subset of the follicular variant of papillary thyroid carcinoma harbors the PAX8-PPARgamma translocation.
|
|
670
|
|
|
‡a
Author's Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant
|
|
670
|
|
|
‡a
Author's Absence of theBRAFand theGRIM-19Mutations in Oncocytic
|
|
670
|
|
|
‡a
Author's Absence of theBRAFand theGRIM-19Mutations in Oncocytic (Hürthle Cell) Solid Cell Nests of the Thyroid
|
|
670
|
|
|
‡a
Author's Accounting for tissue heterogeneity in infrared spectroscopic imaging for accurate diagnosis of thyroid carcinoma subtypes
|
|
670
|
|
|
‡a
Author's Acquisition of BRAF gene mutations is not a requirement for nodal metastasis of papillary thyroid carcinoma
|
|
670
|
|
|
‡a
Author's An extraordinary case of mesenchymal chondrosarcoma metastasis in the thyroid.
|
|
670
|
|
|
‡a
Author's An ultrastructural morphometric study of mossy fiber endings in pigeon, rat and man
|
|
670
|
|
|
‡a
Author's Analysis of 242 cases of gastric carcinoma
|
|
670
|
|
|
‡a
Author's Benign and malignant thyroid lesions show instability at microsatellite loci
|
|
670
|
|
|
‡a
Author's BRAF mutation in solid cell nest hyperplasia associated with papillary thyroid carcinoma. A precursor lesion?
|
|
670
|
|
|
‡a
Author's BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC
|
|
670
|
|
|
‡a
Author's BRAF mutations are associated with some histological types of papillary thyroid carcinoma
|
|
670
|
|
|
‡a
Author's Breast tumor resembling the tall cell variant of papillary thyroid carcinoma: a case report.
|
|
670
|
|
|
‡a
Author's C-Cell-Derived Calcitonin-Free Neuroendocrine Carcinoma of the Thyroid
|
|
670
|
|
|
‡a
Author's C-Cell Hyperplasia and Papillary Thyroid Carcinoma
|
|
670
|
|
|
‡a
Author's Calcitonin receptor expression in medullary thyroid carcinoma
|
|
670
|
|
|
‡a
Author's Carcinoma arising in gastric hyperplastic polyps
|
|
670
|
|
|
‡a
Author's Carcinoma of the thyroid with ewing family tumor elements and favorable prognosis: report of a second case
|
|
670
|
|
|
‡a
Author's Carcinoma of the thyroid with Ewing/PNET family tumor elements: a tumor of unknown histogenesis
|
|
670
|
|
|
‡a
Author's CDX2 Expression in Some Variants of Papillary Thyroid Carcinoma
|
|
670
|
|
|
‡a
Author's Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells
|
|
670
|
|
|
‡a
Author's Coexistence of TERT promoter and BRAF mutations in papillary thyroid carcinoma: added value in patient prognosis?
|
|
670
|
|
|
‡a
Author's Columnar-cell carcinoma. Another variant of poorly differentiated carcinoma of the thyroid
|
|
670
|
|
|
‡a
Author's Comments on: Mutations in Mitochondrial Control Region DNA in Gastric Tumours of Japanese Patients, Tamura, et al. Eur J Cancer 1999, 35, 316–319
|
|
670
|
|
|
‡a
Author's Comparative morphometric study of the cells of the third proximal segment of the rat kidney under different conditions of fixation
|
|
670
|
|
|
‡a
Author's Concurrent production of calcitonin and thyroglobulin by the same neoplastic cells
|
|
670
|
|
|
‡a
Author's Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid
|
|
670
|
|
|
‡a
Author's CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension
|
|
670
|
|
|
‡a
Author's Cribriform-Morular Variant of Papillary Thyroid Carcinoma
|
|
670
|
|
|
‡a
Author's Cribriform-Morular Variant of Papillary Thyroid Carcinoma Displaying Poorly Differentiated Features
|
|
670
|
|
|
‡a
Author's Current thoughts on the histopathogenesis of gastric cancer.
|
|
670
|
|
|
‡a
Author's Cystic tumor of the atrioventricular node of the heart appears to be the heart equivalent of the solid cell nests (ultimobranchial rests) of the thyroid
|
|
670
|
|
|
‡a
Author's Cytogenetic findings in eleven gastric carcinomas.
|
|
670
|
|
|
‡a
Author's Diagnostic and prognostic implications of the PAX8-PPARγ translocation in thyroid carcinomas-a TMA-based study of 226 cases
|
|
670
|
|
|
‡a
Author's Different patterns of beta-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome
|
|
670
|
|
|
‡a
Author's Different types of epithelial cadherin alterations play different roles in human carcinogenesis
|
|
670
|
|
|
‡a
Author's Differentiated thyroid cancer in patients with resistance to thyroid hormone syndrome. A novel case and a review of the literature.
|
|
670
|
|
|
‡a
Author's Difficult cases of thyroid pathology
|
|
670
|
|
|
‡a
Author's Diffuse
|
|
670
|
|
|
‡a
Author's Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma: a clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma.
|
|
670
|
|
|
‡a
Author's Diffuse sclerosing variant of papillary thyroid carcinoma. A clinicopathologic study of 10 cases
|
|
670
|
|
|
‡a
Author's Dimeric sialyl-Le
|
|
670
|
|
|
‡a
Author's Dimeric sialyl-Le(x) expression in gastric carcinoma correlates with venous invasion and poor outcome
|
|
670
|
|
|
‡a
Author's Do cathepsins play a role in the biological behavior of gastric carcinoma?
|
|
670
|
|
|
‡a
Author's Dynamin-Related Protein 1 at the Crossroads of Cancer.
|
|
670
|
|
|
‡a
Author's E-cadherin changes in gastric carcimona
|
|
670
|
|
|
‡a
Author's E-cadherin gene
|
|
670
|
|
|
‡a
Author's E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma
|
|
670
|
|
|
‡a
Author's E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas.
|
|
670
|
|
|
‡a
Author's E-cadherin mutations in gastric carcinoma
|
|
670
|
|
|
‡a
Author's Early Gastric Stump Carcinoma with Rhabdoid Features
|
|
670
|
|
|
‡a
Author's Effect of miR-128 in DNA damage of HL-60 acute myeloid leukemia cells.
|
|
670
|
|
|
‡a
Author's ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome
|
|
670
|
|
|
‡a
Author's Endoscopic ultrasonographic features of gastric mucosa-associated lymphoid tissue lymphoma with a 'pseudocircumvolutory' appearance.
|
|
670
|
|
|
‡a
Author's Epithelial degeneration induced by Helicobacter pylori
|
|
670
|
|
|
‡a
Author's Etiopathogenesis of oncocytomas
|
|
670
|
|
|
‡a
Author's European Perspective on 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Proceedings of an Interactive International Symposium.
|
|
670
|
|
|
‡a
Author's EWSR1 rearrangement is a frequent event in papillary thyroid carcinoma and in carcinoma of the thyroid with Ewing family tumor elements
|
|
670
|
|
|
‡a
Author's EWSR1 rearrangement is a frequent event in papillary thyroid carcinoma and in carcinoma of the thyroid with Ewing family tumor elements (CEFTE).
|
|
670
|
|
|
‡a
Author's Expression of C-erb B2 in tumours and tumour-like lesions of the thyroid
|
|
670
|
|
|
‡a
Author's Expression of Lewis antigens in papillary carcinoma of the thyroid gland
|
|
670
|
|
|
‡a
Author's Expression of mucins (MUC1, MUC2, MUC5AC, and MUC6) and type 1 Lewis antigens in cases with and withoutHelicobacter pyloricolonization in metaplastic glands of the human stomach
|
|
670
|
|
|
‡a
Author's Expression of Simple Mucin Type Antigens and Lewis Type 1 and Type 2 Chain Antigens in the Thyroid Gland: An Immunohistochemical Study of Normal Thyroid Tissues, Benign Lesions, and Malignant Tumors
|
|
670
|
|
|
‡a
Author's Farewell to the dual histogenesis of thyroid tumors?
|
|
670
|
|
|
‡a
Author's Fetal adenomas and minimally invasive follicular carcinomas of the thyroid frequently display a triploid or near triploid DNA pattern
|
|
670
|
|
|
‡a
Author's Follicular, papillary, and "hybrid" carcinomas of the thyroid.
|
|
670
|
|
|
‡a
Author's Follicular thyroid carcinoma
|
|
670
|
|
|
‡a
Author's Follicular thyroid carcinoma with an unusual glomeruloid pattern of growth
|
|
670
|
|
|
‡a
Author's Frequency of TERT promoter mutations in human cancers
|
|
670
|
|
|
‡a
Author's Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6)
|
|
670
|
|
|
‡a
Author's Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas
|
|
670
|
|
|
‡a
Author's Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment
|
|
670
|
|
|
‡a
Author's Genotyping RHD zygosity using real-time polymerase chain reaction
|
|
670
|
|
|
‡a
Author's Germline succinate dehydrogenase subunit D mutation segregating with familial non-RET C cell hyperplasia.
|
|
670
|
|
|
‡a
Author's GLUT1, MCT1/4 and CD147 overexpression supports the metabolic reprogramming in papillary renal cell carcinoma
|
|
670
|
|
|
‡a
Author's GRIM-19 in Health and Disease.
|
|
670
|
|
|
‡a
Author's H-RAS 81 polymorphism is significantly associated with aneuploidy in follicular tumors of the thyroid
|
|
670
|
|
|
‡a
Author's Head and neck lesions in a cohort irradiated in childhood for tinea capitis treatment
|
|
670
|
|
|
‡a
Author's High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations
|
|
670
|
|
|
‡a
Author's Hobnail Variant of Papillary Thyroid Carcinoma: Clinicopathologic and Molecular Evidence of Progression to Undifferentiated Carcinoma in 2 Cases.
|
|
670
|
|
|
‡a
Author's How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer
|
|
670
|
|
|
‡a
Author's Human papillomaviruses in intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva: a study from Mozambique
|
|
670
|
|
|
‡a
Author's Hürthle cell and mitochondrion-rich papillary carcinomas of the thyroid gland: an ultrastructural and immunocytochemical study
|
|
670
|
|
|
‡a
Author's Hürthle-cell lesions of the thyroid: a combined study using transmission electron microscopy, scanning electron microscopy, and immunocytochemistry
|
|
670
|
|
|
‡a
Author's Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance.
|
|
670
|
|
|
‡a
Author's Hyalinizing trabecular adenoma of the thyroid
|
|
670
|
|
|
‡a
Author's Hyalinizing trabecular adenoma of the thyroid (case of the Ullensvang course). Hyalinizing spindle cell tumor of the thyroid with dual differentiation (variant of the so-called hyalinizing trabecular adenoma)
|
|
670
|
|
|
‡a
Author's Identification of a paired box gene 8–peroxisome proliferator-activated receptor gamma
|
|
670
|
|
|
‡a
Author's Identification of a paired box gene 8–peroxisome proliferator-activated receptor gamma (PAX8–PPARγ) rearrangement mosaicism in a patient with an autonomous functioning follicular thyroid carcinoma bearing an activating mutation in the TSH recept
|
|
670
|
|
|
‡a
Author's IL6-174 G>C Polymorphism (rs1800795) Association with Late Effects of Low Dose Radiation Exposure in the Portuguese Tinea Capitis Cohort
|
|
670
|
|
|
‡a
Author's Ileo-colonic infiltration in acute myeloid leukemia.
|
|
670
|
|
|
‡a
Author's Immunohistochemical Analysis of Ras oncogene p21 Product in Human Gastric Carcinomas and their Adjacent Mucosas
|
|
670
|
|
|
‡a
Author's Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid
|
|
670
|
|
|
‡a
Author's Immunohistochemical expression of oncofetal fibronectin in benign and malignant lesions of the stomach
|
|
670
|
|
|
‡a
Author's Immunohistochemical profile of synovial sarcoma with emphasis on the epithelial-type differentiation. A study of 49 primary tumours, recurrences and metastases
|
|
670
|
|
|
‡a
Author's Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins
|
|
670
|
|
|
‡a
Author's Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas
|
|
670
|
|
|
‡a
Author's In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinib.
|
|
670
|
|
|
‡a
Author's In vitro transforming potential, intracellular signaling properties, and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu, and Arg886Trp
|
|
670
|
|
|
‡a
Author's Increased lymphangiogenesis in Riedel thyroiditis
|
|
670
|
|
|
‡a
Author's Increased lymphangiogenesis in Riedel thyroiditis (Immunoglobulin G4-related thyroid disease)
|
|
670
|
|
|
‡a
Author's Increasing levels of MYC and MET co-amplification during tumor progression of a case of gastric cancer
|
|
670
|
|
|
‡a
Author's Inhibitory Effects of Antagonists of Growth Hormone-Releasing Hormone
|
|
670
|
|
|
‡a
Author's Inhibitory Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) in Thyroid Cancer
|
|
670
|
|
|
‡a
Author's Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma
|
|
670
|
|
|
‡a
Author's Intracytoplasmic bodies in the myocardium
|
|
670
|
|
|
‡a
Author's Intragenic mutations in thyroid cancer.
|
|
670
|
|
|
‡a
Author's Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma.
|
|
670
|
|
|
‡a
Author's Introduction
|
|
670
|
|
|
‡a
Author's Is BRAF mutation screening useful for preoperative risk stratification in papillary thyroid cancer?
|
|
670
|
|
|
‡a
Author's Isochromosome 8q. A recurrent change in gastric carcinoma
|
|
670
|
|
|
‡a
Author's Ki67 labelling index in gastric carcinomas. An immunohistochemical study using double staining for the evaluation of the proliferative activity of diffuse-type carcinomas
|
|
670
|
|
|
‡a
Author's Lipomatous haemangiopericytoma (adipocytic variant of solitary fibrous tumour) of the thyroid
|
|
670
|
|
|
‡a
Author's Loss of Y chromosome in gastric carcinoma
|
|
670
|
|
|
‡a
Author's Malignant thyroid teratoma: report of an aggressive tumor in a 64-year-old man.
|
|
670
|
|
|
‡a
Author's Medullary carcinoma of the thyroid gland: an immunocytochemical study
|
|
670
|
|
|
‡a
Author's MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
|
|
670
|
|
|
‡a
Author's Metastatic thyroid carcinoma arising from congenital goiter due to mutation in the thyroperoxidase gene
|
|
670
|
|
|
‡a
Author's Microsatellite instability at multiple loci in gastric carcinoma: Clinicopathologic implications and prognosis
|
|
670
|
|
|
‡a
Author's Microsatellite instability in hyperplastic and adenomatous polyps of the stomach
|
|
670
|
|
|
‡a
Author's Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma
|
|
670
|
|
|
‡a
Author's Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy
|
|
670
|
|
|
‡a
Author's Mitochondrial DNA 'common' deletion in Hürthle cell lesions of the thyroid
|
|
670
|
|
|
‡a
Author's Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration
|
|
670
|
|
|
‡a
Author's Mixed carcinoma of the stomach: a clinicopathological entity
|
|
670
|
|
|
‡a
Author's Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening
|
|
670
|
|
|
‡a
Author's Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines
|
|
670
|
|
|
‡a
Author's Molecular Aspects of Thyroid Calcification
|
|
670
|
|
|
‡a
Author's Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes
|
|
670
|
|
|
‡a
Author's MSI-L gastric carcinomas share the hMLH1 methylation status of MSI-H carcinomas but not their clinicopathological profile
|
|
670
|
|
|
‡a
Author's mTOR activation in medullary thyroid carcinoma with RAS mutation.
|
|
670
|
|
|
‡a
Author's mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma.
|
|
670
|
|
|
‡a
Author's MUC1 gene polymorphism and gastric cancer--an epidemiological study.
|
|
670
|
|
|
‡a
Author's Mucins and mucin-associated carbohydrate antigens expression in gastric carcinoma cell lines
|
|
670
|
|
|
‡a
Author's Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex.
|
|
670
|
|
|
‡a
Author's Neuroendocrine markers and sustentacular cell count in benign and malignant pheochromocytomas - a comparative study.
|
|
670
|
|
|
‡a
Author's New Elements for an Updated Classification of the Carcinomas of the Stomach
|
|
670
|
|
|
‡a
Author's New WHO classification of thyroid tumors: a pragmatic categorization of thyroid gland neoplasms
|
|
670
|
|
|
‡a
Author's Next-generation pathology--surveillance of tumor microecology
|
|
670
|
|
|
‡a
Author's Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma.
|
|
670
|
|
|
‡a
Author's Oncocytic lesions of the thyroid, kidney, salivary glands, adrenal cortex, and parathyroid glands
|
|
670
|
|
|
‡a
Author's Organoid tumor in the thyroid gland.
|
|
670
|
|
|
‡a
Author's Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior
|
|
670
|
|
|
‡a
Author's Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma
|
|
670
|
|
|
‡a
Author's Other Rare Tumours and Tumour-Like Lesions
|
|
670
|
|
|
‡a
Author's OXPHOS dysfunction regulates integrin-β1 modifications and enhances cell motility and migration.
|
|
670
|
|
|
‡a
Author's p53 alterations in gastric carcinoma:
|
|
670
|
|
|
‡a
Author's p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin
|
|
670
|
|
|
‡a
Author's Pancreatic mucinous cystadenocarcinoma with a mural nodule of anaplastic carcinoma
|
|
670
|
|
|
‡a
Author's Papillary and mucoepidermoid carcinoma of the thyroid with anaplastic transformation: a case report with histologic and immunohistochemical findings that support a provocative histogenetic hypothesis
|
|
670
|
|
|
‡a
Author's Papillary carcinomas of the thyroid have pore-deficient nuclei
|
|
670
|
|
|
‡a
Author's Papillary thyroid microcarcinoma: how to diagnose and manage this epidemic?
|
|
670
|
|
|
‡a
Author's Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: an immunohistochemical study of simple and stratified epithelial-type cytokeratins
|
|
670
|
|
|
‡a
Author's PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.
|
|
670
|
|
|
‡a
Author's Pitfalls in Challenging Thyroid Tumors: Emphasis on Differential Diagnosis and Ancillary Biomarkers
|
|
670
|
|
|
‡a
Author's pmTOR is a marker of aggressiveness in papillary thyroid carcinomas
|
|
670
|
|
|
‡a
Author's PNET with neuroendocrine differentiation of the lung: Report of an unusual entity.
|
|
670
|
|
|
‡a
Author's Polymorphisms in the TNFA and IL6 genes represent risk factors for autoimmune thyroid disease
|
|
670
|
|
|
‡a
Author's Poorly Differentiated and Undifferentiated Thyroid Carcinomas
|
|
670
|
|
|
‡a
Author's Primitive neuroectodermal tumor (peripheral neuroblastoma)
|
|
670
|
|
|
‡a
Author's Prognostic biomarkers in thyroid cancer
|
|
670
|
|
|
‡a
Author's Prognostic factors in differentiated thyroid gland carcinoma
|
|
670
|
|
|
‡a
Author's Prognostic significance of some pathologic factors in breast carcinoma
|
|
670
|
|
|
‡a
Author's Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations.
|
|
670
|
|
|
‡a
Author's Proliferative activity of synovial sarcoma: an immunohistochemical evaluation of Ki-67 labeling indices of 52 primary and recurrent tumors
|
|
670
|
|
|
‡a
Author's pS2 protein expression in gastric carcinoma. An immunohistochemical and immunoradiometric study
|
|
670
|
|
|
‡a
Author's Rare Familial Tumours
|
|
670
|
|
|
‡a
Author's Rare Follicular Tumours
|
|
670
|
|
|
‡a
Author's Rare Papillary Thyroid Carcinomas
|
|
670
|
|
|
‡a
Author's Re. ‘Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways’
|
|
670
|
|
|
‡a
Author's RE: TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.
|
|
670
|
|
|
‡a
Author's Recent advances in cytometry, cytogenetics and molecular genetics of thyroid tumours and tumour-like lesions.
|
|
670
|
|
|
‡a
Author's Reply to: Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas
|
|
670
|
|
|
‡a
Author's Reply to 'The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors'
|
|
670
|
|
|
‡a
Author's RET/PTC rearrangement is prevalent in follicular Hürthle cell carcinomas.
|
|
670
|
|
|
‡a
Author's Round cell sarcoma after clear cell sarcoma remission
|
|
670
|
|
|
‡a
Author's Sialosyl Tn antigen expression is associated with the prognosis of patients with advanced gastric cancer
|
|
670
|
|
|
‡a
Author's Sialyl-TN expression in gastric carcinoma
|
|
670
|
|
|
‡a
Author's Signet Ring Cell Carcinoma of the Stomach: A Morphometric, Ultrastructural, and DNA Cytometric Study
|
|
670
|
|
|
‡a
Author's Small-Cell
|
|
670
|
|
|
‡a
Author's Small-Cell (Basaloid) Thyroid Carcinoma
|
|
670
|
|
|
‡a
Author's Small cell tumors of the thyroid gland: a review
|
|
670
|
|
|
‡a
Author's Small Cell Tumours
|
|
670
|
|
|
‡a
Author's Small papillary thyroid cancers—is BRAF of prognostic value?
|
|
670
|
|
|
‡a
Author's Solid cell nests of the thyroid: light microscopy and immunohistochemical profile
|
|
670
|
|
|
‡a
Author's Solitary fibrous tumor of the thyroid
|
|
670
|
|
|
‡a
Author's Solitary fibrous tumour of the thyroid: clinicopathological, immunohistochemical and ultrastructural study of three cases
|
|
670
|
|
|
‡a
Author's Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid.
|
|
670
|
|
|
‡a
Author's Somatic but not germline mutation of the APC gene in a case of cribriform-morular variant of papillary thyroid carcinoma
|
|
670
|
|
|
‡a
Author's Spindle cell variant of papillary thyroid carcinoma
|
|
670
|
|
|
‡a
Author's Sporadic gastric carcinomas with microsatellite instability display a particular clinicopathologic profile.
|
|
670
|
|
|
‡a
Author's STAT3 negatively regulates thyroid tumorigenesis
|
|
670
|
|
|
‡a
Author's Stimulated thyroglobulin at recombinant human TSH-aided ablation predicts disease-free status one year later
|
|
670
|
|
|
‡a
Author's Surgical pathology versus molecular biology
|
|
670
|
|
|
‡a
Author's Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genes
|
|
670
|
|
|
‡a
Author's Synaptic vesicles and other organelles of human mossy fibre endings. A morphometric study
|
|
670
|
|
|
‡a
Author's T (Thomsen?Friedenreich) antigen and other simple mucin-type carbohydrate antigens in precursor lesions of gastric carcinoma
|
|
670
|
|
|
‡a
Author's Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas
|
|
670
|
|
|
‡a
Author's Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests
|
|
670
|
|
|
‡a
Author's Telomerase promoter mutations in cancer: an emerging molecular biomarker?
|
|
670
|
|
|
‡a
Author's Telomere Maintenance Mechanisms in Cancer.
|
|
670
|
|
|
‡a
Author's TERT biology and function in cancer: beyond immortalisation
|
|
670
|
|
|
‡a
Author's TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease
|
|
670
|
|
|
‡a
Author's TERT promoter mutations: a genetic signature of benign and malignant thyroid tumours occurring in the context of tinea capitis irradiation
|
|
670
|
|
|
‡a
Author's TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas
|
|
670
|
|
|
‡a
Author's TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes
|
|
670
|
|
|
‡a
Author's TERT promoter mutations in skin cancer: the effects of sun exposure and X-irradiation.
|
|
670
|
|
|
‡a
Author's TGF-beta/Smad pathway and BRAF mutation play different roles in circumscribed and infiltrative papillary thyroid carcinoma
|
|
670
|
|
|
‡a
Author's Thalidomide-induced acute cholestatic hepatitis: case report and review of the literature.
|
|
670
|
|
|
‡a
Author's The biology and the genetics of Hurthle cell tumors of the thyroid.
|
|
670
|
|
|
‡a
Author's The common deletion of mitochondrial DNA is found in goiters and thyroid tumors with and without oxyphil cell change
|
|
670
|
|
|
‡a
Author's The diagnostic significance of intracytoplasmic lumina in metastatic neoplasms
|
|
670
|
|
|
‡a
Author's The diagnostic value of flow cytometric DNA measurements in selected disorders of the human thyroid
|
|
670
|
|
|
‡a
Author's The effects of different methods of fixation on central nervous system synaptic pinocytotic vesicles
|
|
670
|
|
|
‡a
Author's The fine structure of follicular thyroid adenomas
|
|
670
|
|
|
‡a
Author's The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors.
|
|
670
|
|
|
‡a
Author's The number of parallel fibre-Purkinje dendrite synapses. A morphometric evaluation
|
|
670
|
|
|
‡a
Author's The p75 neurotrophin receptor is widely expressed in conventional papillary thyroid carcinoma
|
|
670
|
|
|
‡a
Author's The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases
|
|
670
|
|
|
‡a
Author's The presence of solid cell nests
|
|
670
|
|
|
‡a
Author's The presence of solid cell nests (SCNS) within the thyroid parenchyma of the isthmus lobe
|
|
670
|
|
|
‡a
Author's The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.
|
|
670
|
|
|
‡a
Author's The Saga of Rhabdoid Cells and Rhabdoid Tumors
|
|
670
|
|
|
‡a
Author's The ultrastructural spectrum of synovial sarcomas: a study of the epithelial type differentiation of primary tumors, recurrences, and metastases
|
|
670
|
|
|
‡a
Author's Therapeutic Options
|
|
670
|
|
|
‡a
Author's Thyroid and Parathyroid Glands
|
|
670
|
|
|
‡a
Author's Thyroid and parathyroid tumours in patients submitted to X-ray scalp epilation during the tinea capitis eradication campaign in the North of Portugal
|
|
670
|
|
|
‡a
Author's Thyroid and parathyroid tumours in patients submitted to X-ray scalp epilation during the tinea capitis eradication campaign in the North of Portugal (1950-1963).
|
|
670
|
|
|
‡a
Author's Transmission electron microscopy and immunocytochemistry in the diagnosis of thyroid tumors
|
|
670
|
|
|
‡a
Author's Tumor-in-tumor of the thyroid with basaloid differentiation: a lesion with a solid cell nest neoplastic component?
|
|
670
|
|
|
‡a
Author's Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients’ age but not with tumour aggressiveness
|
|
670
|
|
|
‡a
Author's Ultrastructural and electron immunohistochemical features of medullary thyroid carcinoma
|
|
670
|
|
|
‡a
Author's Vascular invasion in thyroid and gastric carcinomas.
|
|
670
|
|
|
‡a
Author's Warthin's tumour.
|
|
670
|
|
|
‡a
Author's What's going on in nerve sheath tumors?
|
|
670
|
|
|
‡a
Author's WNT-inducible signaling pathway protein 3, WISP-3, is mutated in microsatellite unstable gastrointestinal carcinomas but not in endometrial carcinomas
|
|
670
|
|
|
‡a
Author's ভূমিকা
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/NII|DA04849325
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/DNB|1177399466
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/ISNI|0000000068678687
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/PTBNP|1056572
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/viaf/2215150647102110860001
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/SUDOC|162008376
|
|
670
|
|
|
‡a
wikidata site links
‡u
https://pt.wikipedia.org/wiki/Manuel_Sobrinho_Simões
|
|
909
|
|
|
‡a
(scopus) 7101632183
‡9
1
|
|
909
|
|
|
‡a
(orcid) 0000000316131235
‡9
1
|
|
912
|
|
|
‡a
introduction
‡A
Introduction
‡9
1
|
|
912
|
|
|
‡a
ভমক
‡A
ভূমিকা
‡9
1
|
|
919
|
|
|
‡a
retertpromotermutationstatusasanindependentprognosticfactorincutaneousmelanoma
‡A
RE: TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.
‡9
1
|
|
919
|
|
|
‡a
retptcrearrangementisprevalentinfollicularhurthlecellcarcinomas
‡A
RET/PTC rearrangement is prevalent in follicular Hürthle cell carcinomas.
‡9
1
|
|
919
|
|
|
‡a
recellularphenotypesofdifferentiatedtypeadenocarcinomasandprecancerouslesionsofthestomacharedependentonthegeneticpathways
‡A
Re. ‘Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways’
‡9
1
|
|
919
|
|
|
‡a
roundcellsarcomaafterclearcellsarcomaremission
‡A
Round cell sarcoma after clear cell sarcoma remission
‡9
1
|
|
919
|
|
|
‡a
rarepapillarythyroidcarcinomas
‡A
Rare Papillary Thyroid Carcinomas
‡9
1
|
|
919
|
|
|
‡a
sialosyltnantigenexpressionisassociatedwiththeprognosisofpatientswithadvancedgastriccancer
‡A
Sialosyl Tn antigen expression is associated with the prognosis of patients with advanced gastric cancer
‡9
1
|
|
919
|
|
|
‡a
rarefolliculartumours
‡A
Rare Follicular Tumours
‡9
1
|
|
919
|
|
|
‡a
sialyltnexpressioningastriccarcinoma
‡A
Sialyl-TN expression in gastric carcinoma
‡9
1
|
|
919
|
|
|
‡a
rarefamilialtumours
‡A
Rare Familial Tumours
‡9
1
|
|
919
|
|
|
‡a
signetringcellcarcinomaofthestomachamorphometricultrastructuralanddnacytometricstudy
‡A
Signet Ring Cell Carcinoma of the Stomach: A Morphometric, Ultrastructural, and DNA Cytometric Study
‡9
1
|
|
919
|
|
|
‡a
ps2proteinexpressioningastriccarcinomaanimmunohistochemicalandimmunoradiometricstudy
‡A
pS2 protein expression in gastric carcinoma. An immunohistochemical and immunoradiometric study
‡9
1
|
|
919
|
|
|
‡a
smallcell
‡A
Small-Cell
‡9
1
|
|
919
|
|
|
‡a
proliferativeactivityofsynovialsarcomaanimmunohistochemicalevaluationofki67labelingindicesof52primaryandrecurrenttumors
‡A
Proliferative activity of synovial sarcoma: an immunohistochemical evaluation of Ki-67 labeling indices of 52 primary and recurrent tumors
‡9
1
|
|
919
|
|
|
‡a
proliferationandsurvivalmoleculesimplicatedintheinhibitionofbrafpathwayinthyroidcancercellsharbouringdifferentgeneticmutations
‡A
Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations.
‡9
1
|
|
919
|
|
|
‡a
prognosticsignificanceofsomepathologicfactorsinbreastcarcinoma
‡A
Prognostic significance of some pathologic factors in breast carcinoma
‡9
1
|
|
919
|
|
|
‡a
prognosticfactorsindifferentiatedthyroidglandcarcinoma
‡A
Prognostic factors in differentiated thyroid gland carcinoma
‡9
1
|
|
919
|
|
|
‡a
prognosticbiomarkersinthyroidcancer
‡A
Prognostic biomarkers in thyroid cancer
‡9
1
|
|
919
|
|
|
‡a
primitiveneuroectodermaltumorperipheralneuroblastoma
‡A
Primitive neuroectodermal tumor (peripheral neuroblastoma)
‡9
1
|
|
919
|
|
|
‡a
poorlydifferentiatedandundifferentiatedthyroidcarcinomas
‡A
Poorly Differentiated and Undifferentiated Thyroid Carcinomas
‡9
1
|
|
919
|
|
|
‡a
polymorphismsinthetnfaandil6genesrepresentriskfactorsforautoimmunethyroiddisease
‡A
Polymorphisms in the TNFA and IL6 genes represent risk factors for autoimmune thyroid disease
‡9
1
|
|
919
|
|
|
‡a
pnetwithneuroendocrinedifferentiationofthelungreportofanunusualentity
‡A
PNET with neuroendocrine differentiation of the lung: Report of an unusual entity.
‡9
1
|
|
919
|
|
|
‡a
pmtorisamarkerofaggressivenessinpapillarythyroidcarcinomas
‡A
pmTOR is a marker of aggressiveness in papillary thyroid carcinomas
‡9
1
|
|
919
|
|
|
‡a
pitfallsinchallengingthyroidtumorsemphasisondifferentialdiagnosisandancillarybiomarkers
‡A
Pitfalls in Challenging Thyroid Tumors: Emphasis on Differential Diagnosis and Ancillary Biomarkers
‡9
1
|
|
919
|
|
|
‡a
pax8ppargammarearrangementisfrequentlydetectedinthefollicularvariantofpapillarythyroidcarcinoma
‡A
PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.
‡9
1
|
|
919
|
|
|
‡a
patternofexpressionofintermediatecytokeratinfilamentsinthethyroidglandanimmunohistochemicalstudyofsimpleandstratifiedepithelialtypecytokeratins
‡A
Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: an immunohistochemical study of simple and stratified epithelial-type cytokeratins
‡9
1
|
|
919
|
|
|
‡a
papillarythyroidmicrocarcinomahowtodiagnoseandmanagethisepidemic
‡A
Papillary thyroid microcarcinoma: how to diagnose and manage this epidemic?
‡9
1
|
|
919
|
|
|
‡a
papillarycarcinomasofthethyroidhaveporedeficientnuclei
‡A
Papillary carcinomas of the thyroid have pore-deficient nuclei
‡9
1
|
|
919
|
|
|
‡a
papillaryandmucoepidermoidcarcinomaofthethyroidwithanaplastictransformationacasereportwithhistologicandimmunohistochemicalfindingsthatsupportaprovocativehistogenetichypothesis
‡A
Papillary and mucoepidermoid carcinoma of the thyroid with anaplastic transformation: a case report with histologic and immunohistochemical findings that support a provocative histogenetic hypothesis
‡9
1
|
|
919
|
|
|
‡a
pancreaticmucinouscystadenocarcinomawithamuralnoduleofanaplasticcarcinoma
‡A
Pancreatic mucinous cystadenocarcinoma with a mural nodule of anaplastic carcinoma
‡9
1
|
|
919
|
|
|
‡a
p63expressioninsolidcellnestsofthethyroidfurtherevidenceforastemcellorigin
‡A
p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin
‡9
1
|
|
919
|
|
|
‡a
p53alterationsingastriccarcinoma
‡A
p53 alterations in gastric carcinoma:
‡9
1
|
|
919
|
|
|
‡a
oxphosdysfunctionregulatesintegrinβ1modificationsandenhancescellmotilityandmigration
‡A
OXPHOS dysfunction regulates integrin-β1 modifications and enhances cell motility and migration.
‡9
1
|
|
919
|
|
|
‡a
otherraretumoursandtumourlikelesions
‡A
Other Rare Tumours and Tumour-Like Lesions
‡9
1
|
|
919
|
|
|
‡a
osteopontinexpressioniscorrelatedwithdifferentiationandgoodprognosisinmedullarythyroidcarcinoma
‡A
Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma
‡9
1
|
|
919
|
|
|
‡a
osteopontinasplicevariantisoverexpressedinpapillarythyroidcarcinomaandmodulatesinvasivebehavior
‡A
Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior
‡9
1
|
|
919
|
|
|
‡a
organoidtumorinthethyroidgland
‡A
Organoid tumor in the thyroid gland.
‡9
1
|
|
919
|
|
|
‡a
oncocyticlesionsofthethyroidkidneysalivaryglandsadrenalcortexandparathyroidglands
‡A
Oncocytic lesions of the thyroid, kidney, salivary glands, adrenal cortex, and parathyroid glands
‡9
1
|
|
919
|
|
|
‡a
observervariationinthediagnosisoffollicularvariantofpapillarythyroidcarcinoma
‡A
Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma.
‡9
1
|
|
919
|
|
|
‡a
nextgenerationpathologysurveillanceoftumormicroecology
‡A
Next-generation pathology--surveillance of tumor microecology
‡9
1
|
|
919
|
|
|
‡a
newwhoclassificationofthyroidtumorsapragmaticcategorizationofthyroidglandneoplasms
‡A
New WHO classification of thyroid tumors: a pragmatic categorization of thyroid gland neoplasms
‡9
1
|
|
919
|
|
|
‡a
newelementsforanupdatedclassificationofthecarcinomasofthestomach
‡A
New Elements for an Updated Classification of the Carcinomas of the Stomach
‡9
1
|
|
919
|
|
|
‡a
neuroendocrinemarkersandsustentacularcellcountinbenignandmalignantpheochromocytomasacomparativestudy
‡A
Neuroendocrine markers and sustentacular cell count in benign and malignant pheochromocytomas - a comparative study.
‡9
1
|
|
919
|
|
|
‡a
mucoepidermoidcarcinomaofthethyroidatumourhistotypecharacterisedbypcadherinneoexpressionandmarkedabnormalitiesofecadherincateninscomplex
‡A
Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex.
‡9
1
|
|
919
|
|
|
‡a
mucinsandmucinassociatedcarbohydrateantigensexpressioningastriccarcinomacelllines
‡A
Mucins and mucin-associated carbohydrate antigens expression in gastric carcinoma cell lines
‡9
1
|
|
919
|
|
|
‡a
muc1genepolymorphismandgastriccanceranepidemiologicalstudy
‡A
MUC1 gene polymorphism and gastric cancer--an epidemiological study.
‡9
1
|
|
919
|
|
|
‡a
mtorpathwayoveractivationinbrafmutatedpapillarythyroidcarcinoma
‡A
mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma.
‡9
1
|
|
919
|
|
|
‡a
mtoractivationinmedullarythyroidcarcinomawithrasmutation
‡A
mTOR activation in medullary thyroid carcinoma with RAS mutation.
‡9
1
|
|
919
|
|
|
‡a
msi50gastriccarcinomassharethehmlh1methylationstatusofmsihcarcinomasbutnottheirclinicopathologicalprofile
‡A
MSI-L gastric carcinomas share the hMLH1 methylation status of MSI-H carcinomas but not their clinicopathological profile
‡9
1
|
|
919
|
|
|
‡a
molecularmarkersinvolvedintumorigenesisofthyroidcarcinomafocusonaggressivehistotypes
‡A
Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes
‡9
1
|
|
919
|
|
|
‡a
molecularaspectsofthyroidcalcification
‡A
Molecular Aspects of Thyroid Calcification
‡9
1
|
|
919
|
|
|
‡a
smallcellbasaloidthyroidcarcinoma
‡A
Small-Cell (Basaloid) Thyroid Carcinoma
‡9
1
|
|
919
|
|
|
‡a
smallcelltumorsofthethyroidglandareview
‡A
Small cell tumors of the thyroid gland: a review
‡9
1
|
|
919
|
|
|
‡a
smallcelltumours
‡A
Small Cell Tumours
‡9
1
|
|
919
|
|
|
‡a
smallpapillarythyroidcancersisbrafofprognosticvalue
‡A
Small papillary thyroid cancers—is BRAF of prognostic value?
‡9
1
|
|
919
|
|
|
‡a
solidcellnestsofthethyroidlightmicroscopyandimmunohistochemicalprofile
‡A
Solid cell nests of the thyroid: light microscopy and immunohistochemical profile
‡9
1
|
|
919
|
|
|
‡a
solitaryfibroustumorofthethyroid
‡A
Solitary fibrous tumor of the thyroid
‡9
1
|
|
919
|
|
|
‡a
solitaryfibroustumourofthethyroidclinicopathologicalimmunohistochemicalandultrastructuralstudyof3cases
‡A
Solitary fibrous tumour of the thyroid: clinicopathological, immunohistochemical and ultrastructural study of three cases
‡9
1
|
|
919
|
|
|
‡a
somaticandgermlinemutationingrim19adualfunctiongeneinvolvedinmitochondrialmetabolismandcelldeathislinkedtomitochondrionrichhurthlecelltumoursofthethyroid
‡A
Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid.
‡9
1
|
|
919
|
|
|
‡a
somaticbutnotgermlinemutationoftheapcgeneinacaseofcribriformmorularvariantofpapillarythyroidcarcinoma
‡A
Somatic but not germline mutation of the APC gene in a case of cribriform-morular variant of papillary thyroid carcinoma
‡9
1
|
|
919
|
|
|
‡a
spindlecellvariantofpapillarythyroidcarcinoma
‡A
Spindle cell variant of papillary thyroid carcinoma
‡9
1
|
|
919
|
|
|
‡a
sporadicgastriccarcinomaswithmicrosatelliteinstabilitydisplayaparticularclinicopathologicprofile
‡A
Sporadic gastric carcinomas with microsatellite instability display a particular clinicopathologic profile.
‡9
1
|
|
919
|
|
|
‡a
stat3negativelyregulatesthyroidtumorigenesis
‡A
STAT3 negatively regulates thyroid tumorigenesis
‡9
1
|
|
919
|
|
|
‡a
stimulatedthyroglobulinatrecombinanthumantshaidedablationpredictsdiseasefreestatus1yearlater
‡A
Stimulated thyroglobulin at recombinant human TSH-aided ablation predicts disease-free status one year later
‡9
1
|
|
919
|
|
|
‡a
surgicalpathologyversusmolecularbiology
‡A
Surgical pathology versus molecular biology
‡9
1
|
|
919
|
|
|
‡a
surveyof548oncogenicfusiontranscriptsinthyroidtumorssupportstheimportanceofthealreadyestablishedthyroidfusionsgenes
‡A
Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genes
‡9
1
|
|
919
|
|
|
‡a
synapticvesiclesandotherorganellesofhumanmossyfibreendingsamorphometricstudy
‡A
Synaptic vesicles and other organelles of human mossy fibre endings. A morphometric study
‡9
1
|
|
919
|
|
|
‡a
tthomsenfriedenreichantigenandothersimplemucintypecarbohydrateantigensinprecursorlesionsofgastriccarcinoma
‡A
T (Thomsen?Friedenreich) antigen and other simple mucin-type carbohydrate antigens in precursor lesions of gastric carcinoma
‡9
1
|
|
919
|
|
|
‡a
telomeraseandncadherindifferentialimportanceinadrenocorticalcancersandadenomas
‡A
Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas
‡9
1
|
|
919
|
|
|
‡a
telomeraseexpressionandproliferativeactivitysuggestastemcellroleforthyroidsolidcellnests
‡A
Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests
‡9
1
|
|
919
|
|
|
‡a
telomerasepromotermutationsincanceranemergingmolecularbiomarker
‡A
Telomerase promoter mutations in cancer: an emerging molecular biomarker?
‡9
1
|
|
919
|
|
|
‡a
telomeremaintenancemechanismsincancer
‡A
Telomere Maintenance Mechanisms in Cancer.
‡9
1
|
|
919
|
|
|
‡a
tertbiologyandfunctionincancerbeyondimmortalisation
‡A
TERT biology and function in cancer: beyond immortalisation
‡9
1
|
|
919
|
|
|
‡a
tertbrafandnrasinprimarythyroidcancerandmetastaticdisease
‡A
TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease
‡9
1
|
|
919
|
|
|
‡a
tertpromotermutationsageneticsignatureofbenignandmalignantthyroidtumoursoccurringinthecontextoftineacapitisirradiation
‡A
TERT promoter mutations: a genetic signature of benign and malignant thyroid tumours occurring in the context of tinea capitis irradiation
‡9
1
|
|
919
|
|
|
‡a
tertpromotermutationsareamajorindicatorofpooroutcomeindifferentiatedthyroidcarcinomas
‡A
TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas
‡9
1
|
|
919
|
|
|
‡a
tertpromotermutationsinpancreaticendocrinetumoursarerareandmainlyfoundintumoursfrompatientswithhereditarysyndromes
‡A
TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes
‡9
1
|
|
919
|
|
|
‡a
tertpromotermutationsinskincancertheeffectsofsunexposureand10irradiation
‡A
TERT promoter mutations in skin cancer: the effects of sun exposure and X-irradiation.
‡9
1
|
|
919
|
|
|
‡a
tgfbetasmadpathwayandbrafmutationplaydifferentrolesincircumscribedandinfiltrativepapillarythyroidcarcinoma
‡A
TGF-beta/Smad pathway and BRAF mutation play different roles in circumscribed and infiltrative papillary thyroid carcinoma
‡9
1
|
|
919
|
|
|
‡a
thalidomideinducedacutecholestatichepatitiscasereportandreviewoftheliterature
‡A
Thalidomide-induced acute cholestatic hepatitis: case report and review of the literature.
‡9
1
|
|
919
|
|
|
‡a
biologyandthegeneticsofhurthlecelltumorsofthethyroid
‡A
The biology and the genetics of Hurthle cell tumors of the thyroid.
‡9
1
|
|
919
|
|
|
‡a
commondeletionofmitochondrialdnaisfoundingoitersandthyroidtumorswithandwithoutoxyphilcellchange
‡A
The common deletion of mitochondrial DNA is found in goiters and thyroid tumors with and without oxyphil cell change
‡9
1
|
|
919
|
|
|
‡a
diagnosticsignificanceofintracytoplasmicluminainmetastaticneoplasms
‡A
The diagnostic significance of intracytoplasmic lumina in metastatic neoplasms
‡9
1
|
|
919
|
|
|
‡a
diagnosticvalueofflowcytometricdnameasurementsinselecteddisordersofthehumanthyroid
‡A
The diagnostic value of flow cytometric DNA measurements in selected disorders of the human thyroid
‡9
1
|
|
919
|
|
|
‡a
effectsofdifferentmethodsoffixationoncentralnervoussystemsynapticpinocytoticvesicles
‡A
The effects of different methods of fixation on central nervous system synaptic pinocytotic vesicles
‡9
1
|
|
919
|
|
|
‡a
finestructureoffollicularthyroidadenomas
‡A
The fine structure of follicular thyroid adenomas
‡9
1
|
|
919
|
|
|
‡a
newmolecularmarkersddit3stt3aarg2andfam129aarenotusefulindiagnosingthyroidfolliculartumors
‡A
The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors.
‡9
1
|
|
919
|
|
|
‡a
numberofparallelfibrepurkinjedendritesynapsesamorphometricevaluation
‡A
The number of parallel fibre-Purkinje dendrite synapses. A morphometric evaluation
‡9
1
|
|
919
|
|
|
‡a
p75neurotrophinreceptoriswidelyexpressedinconventionalpapillarythyroidcarcinoma
‡A
The p75 neurotrophin receptor is widely expressed in conventional papillary thyroid carcinoma
‡9
1
|
|
919
|
|
|
‡a
preeminenceofgrowthpatternandinvasivenessandthelimitedinfluenceofbrafandrasmutationsintheoccurrenceofpapillarythyroidcarcinomalymphnodemetastases
‡A
The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases
‡9
1
|
|
919
|
|
|
‡a
molecularandgenotypiccharacterizationofhumanthyroidfollicularcellcarcinomaderivedcelllines
‡A
Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines
‡9
1
|
|
919
|
|
|
‡a
presenceofsolidcellnests
‡A
The presence of solid cell nests
‡9
1
|
|
919
|
|
|
‡a
modeloftheearlydevelopmentofdiffusegastriccancerinecadherinmutationcarriersanditsimplicationsforpatientscreening
‡A
Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening
‡9
1
|
|
919
|
|
|
‡a
presenceofsolidcellnestsscnswithinthethyroidparenchymaoftheisthmuslobe
‡A
The presence of solid cell nests (SCNS) within the thyroid parenchyma of the isthmus lobe
‡9
1
|
|
919
|
|
|
‡a
mixedcarcinomaofthestomachaclinicopathologicalentity
‡A
Mixed carcinoma of the stomach: a clinicopathological entity
‡9
1
|
|
919
|
|
|
‡a
prognosticimpactoftertpromotermutationsinglioblastomasismodifiedbythers2853669singlenucleotidepolymorphism
‡A
The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.
‡9
1
|
|
919
|
|
|
‡a
mitochondrialdynamicsproteindrp1isoverexpressedinoncocyticthyroidtumorsandregulatescancercellmigration
‡A
Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration
‡9
1
|
|
919
|
|
|
‡a
sagaofrhabdoidcellsandrhabdoidtumors
‡A
The Saga of Rhabdoid Cells and Rhabdoid Tumors
‡9
1
|
|
919
|
|
|
‡a
mitochondrialdnacommondeletioninhurthlecelllesionsofthethyroid
‡A
Mitochondrial DNA 'common' deletion in Hürthle cell lesions of the thyroid
‡9
1
|
|
919
|
|
|
‡a
ultrastructuralspectrumofsynovialsarcomasastudyoftheepithelialtypedifferentiationofprimarytumorsrecurrencesandmetastases
‡A
The ultrastructural spectrum of synovial sarcomas: a study of the epithelial type differentiation of primary tumors, recurrences, and metastases
‡9
1
|
|
919
|
|
|
‡a
mitochondrial500loopinstabilityinthyroidtumoursisnotamarkerofmalignancy
‡A
Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy
‡9
1
|
|
919
|
|
|
‡a
therapeuticoptions
‡A
Therapeutic Options
‡9
1
|
|
919
|
|
|
‡a
microsatelliteinstabilitymitochondrialdnalargedeletionsandmitochondrialdnamutationsingastriccarcinoma
‡A
Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma
‡9
1
|
|
919
|
|
|
‡a
microsatelliteinstabilityinhyperplasticandadenomatouspolypsofthestomach
‡A
Microsatellite instability in hyperplastic and adenomatous polyps of the stomach
‡9
1
|
|
919
|
|
|
‡a
microsatelliteinstabilityatmultiplelociingastriccarcinomaclinicopathologicimplicationsandprognosis
‡A
Microsatellite instability at multiple loci in gastric carcinoma: Clinicopathologic implications and prognosis
‡9
1
|
|
919
|
|
|
‡a
metastaticthyroidcarcinomaarisingfromcongenitalgoiterduetomutationinthethyroperoxidasegene
‡A
Metastatic thyroid carcinoma arising from congenital goiter due to mutation in the thyroperoxidase gene
‡9
1
|
|
919
|
|
|
‡a
men1intragenicdeletionsmayrepresentthemostprevalentsomaticeventinsporadicprimaryhyperparathyroidism
‡A
MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
‡9
1
|
|
919
|
|
|
‡a
medullarycarcinomaofthethyroidglandanimmunocytochemicalstudy
‡A
Medullary carcinoma of the thyroid gland: an immunocytochemical study
‡9
1
|
|
919
|
|
|
‡a
malignantthyroidteratomareportofanaggressivetumorina64yearoldman
‡A
Malignant thyroid teratoma: report of an aggressive tumor in a 64-year-old man.
‡9
1
|
|
919
|
|
|
‡a
lossofychromosomeingastriccarcinoma
‡A
Loss of Y chromosome in gastric carcinoma
‡9
1
|
|
919
|
|
|
‡a
lipomatoushaemangiopericytomaadipocyticvariantofsolitaryfibroustumourofthethyroid
‡A
Lipomatous haemangiopericytoma (adipocytic variant of solitary fibrous tumour) of the thyroid
‡9
1
|
|
919
|
|
|
‡a
ki67labellinginde xing astriccarcinomasanimmunohistochemicalstudyusingdoublestainingfortheevaluationoftheproliferativeactivityofdiffusetypecarcinomas
‡A
Ki67 labelling index in gastric carcinomas. An immunohistochemical study using double staining for the evaluation of the proliferative activity of diffuse-type carcinomas
‡9
1
|
|
919
|
|
|
‡a
isochromosome8qarecurrentchangeingastriccarcinoma
‡A
Isochromosome 8q. A recurrent change in gastric carcinoma
‡9
1
|
|
919
|
|
|
‡a
isbrafmutationscreeningusefulforpreoperativeriskstratificationinpapillarythyroidcancer
‡A
Is BRAF mutation screening useful for preoperative risk stratification in papillary thyroid cancer?
‡9
1
|
|
919
|
|
|
‡a
intratumourallymphvesseldensityisrelatedtopresenceoflymphnodemetastasesandseparatesencapsulatedfrominfiltrativepapillarythyroidcarcinoma
‡A
Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma.
‡9
1
|
|
919
|
|
|
‡a
intragenicmutationsinthyroidcancer
‡A
Intragenic mutations in thyroid cancer.
‡9
1
|
|
919
|
|
|
‡a
intracytoplasmicbodiesinthemyocardium
‡A
Intracytoplasmic bodies in the myocardium
‡9
1
|
|
919
|
|
|
‡a
interleukin1bandinterleukin1rnpolymorphismsareassociatedwithincreasedriskofgastriccarcinoma
‡A
Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma
‡9
1
|
|
919
|
|
|
‡a
inhibitoryeffectsofantagonistsofgrowthhormonereleasinghormoneghrhinthyroidcancer
‡A
Inhibitory Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) in Thyroid Cancer
‡9
1
|
|
919
|
|
|
‡a
inhibitoryeffectsofantagonistsofgrowthhormonereleasinghormone
‡A
Inhibitory Effects of Antagonists of Growth Hormone-Releasing Hormone
‡9
1
|
|
919
|
|
|
‡a
increasinglevelsofmycandmetcoamplificationduringtumorprogressionofacaseofgastriccancer
‡A
Increasing levels of MYC and MET co-amplification during tumor progression of a case of gastric cancer
‡9
1
|
|
919
|
|
|
‡a
increasedlymphangiogenesisinriedelthyroiditisimmunoglobuling4relatedthyroiddisease
‡A
Increased lymphangiogenesis in Riedel thyroiditis (Immunoglobulin G4-related thyroid disease)
‡9
1
|
|
919
|
|
|
‡a
increasedlymphangiogenesisinriedelthyroiditis
‡A
Increased lymphangiogenesis in Riedel thyroiditis
‡9
1
|
|
919
|
|
|
‡a
invitrotransformingpotentialintracellularsignalingpropertiesandsensitivitytoakinaseinhibitorsorafenibofretprotooncogenevariantsglu511lysser649leuandarg886trp
‡A
In vitro transforming potential, intracellular signaling properties, and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu, and Arg886Trp
‡9
1
|
|
919
|
|
|
‡a
insearchoftheoriginalleukemiccloneinchronicmyeloidleukemiapatientsincompletemolecularremissionafterstemcelltransplantationorimatinib
‡A
In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinib.
‡9
1
|
|
919
|
|
|
‡a
immunohistochemicalstudyoftheexpressionofmuc6mucinandcoexpressionofothersecretedmucinsmuc5acandmuc2inhumangastriccarcinomas
‡A
Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas
‡9
1
|
|
919
|
|
|
‡a
immunohistochemicalstudyoftheexpressionofmuc6mucinandcoexpressionofothersecretedmucins
‡A
Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins
‡9
1
|
|
919
|
|
|
‡a
immunohistochemicalprofileofsynovialsarcomawithemphasisontheepithelialtypedifferentiationastudyof49primarytumoursrecurrencesandmetastases
‡A
Immunohistochemical profile of synovial sarcoma with emphasis on the epithelial-type differentiation. A study of 49 primary tumours, recurrences and metastases
‡9
1
|
|
919
|
|
|
‡a
immunohistochemicalexpressionofoncofetalfibronectininbenignandmalignantlesionsofthestomach
‡A
Immunohistochemical expression of oncofetal fibronectin in benign and malignant lesions of the stomach
‡9
1
|
|
919
|
|
|
‡a
thyroidandparathyroidglands
‡A
Thyroid and Parathyroid Glands
‡9
1
|
|
919
|
|
|
‡a
thyroidandparathyroidtumoursinpatientssubmittedto10rayscalpepilationduringthetineacapitiseradicationcampaigninthenorthofportugal
‡A
Thyroid and parathyroid tumours in patients submitted to X-ray scalp epilation during the tinea capitis eradication campaign in the North of Portugal
‡9
1
|
|
919
|
|
|
‡a
thyroidandparathyroidtumoursinpatientssubmittedto10rayscalpepilationduringthetineacapitiseradicationcampaigninthenorthofportugal1950
‡A
Thyroid and parathyroid tumours in patients submitted to X-ray scalp epilation during the tinea capitis eradication campaign in the North of Portugal (1950-1963).
‡9
1
|
|
919
|
|
|
‡a
transmissionelectronmicroscopyandimmunocytochemistryinthediagnosisofthyroidtumors
‡A
Transmission electron microscopy and immunocytochemistry in the diagnosis of thyroid tumors
‡9
1
|
|
919
|
|
|
‡a
tumorintumorofthethyroidwithbasaloiddifferentiationalesionwithasolidcellnestneoplasticcomponent
‡A
Tumor-in-tumor of the thyroid with basaloid differentiation: a lesion with a solid cell nest neoplastic component?
‡9
1
|
|
919
|
|
|
‡a
typeandprevalenceofbrafmutationsarecloselyassociatedwithpapillarythyroidcarcinomahistotypeandpatientsagebutnotwithtumouraggressiveness
‡A
Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients’ age but not with tumour aggressiveness
‡9
1
|
|
919
|
|
|
‡a
ultrastructuralandelectronimmunohistochemicalfeaturesofmedullarythyroidcarcinoma
‡A
Ultrastructural and electron immunohistochemical features of medullary thyroid carcinoma
‡9
1
|
|
919
|
|
|
‡a
vascularinvasioninthyroidandgastriccarcinomas
‡A
Vascular invasion in thyroid and gastric carcinomas.
‡9
1
|
|
919
|
|
|
‡a
warthinstumour
‡A
Warthin's tumour.
‡9
1
|
|
919
|
|
|
‡a
whatsgoingoninnervesheathtumors
‡A
What's going on in nerve sheath tumors?
‡9
1
|
|
919
|
|
|
‡a
wntinduciblesignalingpathwayprotein3wisp3ismutatedinmicrosatelliteunstablegastrointestinalcarcinomasbutnotinendometrialcarcinomas
‡A
WNT-inducible signaling pathway protein 3, WISP-3, is mutated in microsatellite unstable gastrointestinal carcinomas but not in endometrial carcinomas
‡9
1
|
|
919
|
|
|
‡a
immunohistochemicaldetectionofp53indifferentiatedpoorlydifferentiatedandundifferentiatedcarcinomasofthethyroid
‡A
Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid
‡9
1
|
|
919
|
|
|
‡a
immunohistochemicalanalysisofrasoncogenep21productinhumangastriccarcinomasandtheiradjacentmucosas
‡A
Immunohistochemical Analysis of Ras oncogene p21 Product in Human Gastric Carcinomas and their Adjacent Mucosas
‡9
1
|
|
919
|
|
|
‡a
ileocolonicinfiltrationinacutemyeloidleukemia
‡A
Ileo-colonic infiltration in acute myeloid leukemia.
‡9
1
|
|
919
|
|
|
‡a
il6174g100polymorphismrs1800795associationwithlateeffectsoflowdoseradiationexposureintheportuguesetineacapitiscohort
‡A
IL6-174 G>C Polymorphism (rs1800795) Association with Late Effects of Low Dose Radiation Exposure in the Portuguese Tinea Capitis Cohort
‡9
1
|
|
919
|
|
|
‡a
identificationofapairedboxgene8peroxisomeproliferatoractivatedreceptorgammapax8pparγrearrangementmosaicisminapatientwithanautonomousfunctioningfollicularthyroidcarcinomabearinganactivatingmutationinthetshrecept
‡A
Identification of a paired box gene 8–peroxisome proliferator-activated receptor gamma (PAX8–PPARγ) rearrangement mosaicism in a patient with an autonomous functioning follicular thyroid carcinoma bearing an activating mutation in the TSH recept
‡9
1
|
|
919
|
|
|
‡a
identificationofapairedboxgene8peroxisomeproliferatoractivatedreceptorgamma
‡A
Identification of a paired box gene 8–peroxisome proliferator-activated receptor gamma
‡9
1
|
|
919
|
|
|
‡a
hyalinizingtrabecularadenomaofthethyroidcaseoftheullensvangcoursehyalinizingspindlecelltumorofthethyroidwithdualdifferentiationvariantofthesocalledhyalinizingtrabecularadenoma
‡A
Hyalinizing trabecular adenoma of the thyroid (case of the Ullensvang course). Hyalinizing spindle cell tumor of the thyroid with dual differentiation (variant of the so-called hyalinizing trabecular adenoma)
‡9
1
|
|
919
|
|
|
‡a
hyalinizingtrabecularadenomaofthethyroid
‡A
Hyalinizing trabecular adenoma of the thyroid
‡9
1
|
|
919
|
|
|
‡a
hurthleoncocyticcelltumorsofthyroidetiopathogenesisdiagnosisandclinicalsignificance
‡A
Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance.
‡9
1
|
|
919
|
|
|
‡a
hurthlecelllesionsofthethyroidacombinedstudyusingtransmissionelectronmicroscopyscanningelectronmicroscopyandimmunocytochemistry
‡A
Hürthle-cell lesions of the thyroid: a combined study using transmission electron microscopy, scanning electron microscopy, and immunocytochemistry
‡9
1
|
|
919
|
|
|
‡a
hurthlecellandmitochondrionrichpapillarycarcinomasofthethyroidglandanultrastructuralandimmunocytochemicalstudy
‡A
Hürthle cell and mitochondrion-rich papillary carcinomas of the thyroid gland: an ultrastructural and immunocytochemical study
‡9
1
|
|
919
|
|
|
‡a
humanpapillomavirusesinintraepithelialneoplasiaandsquamouscellcarcinomaoftheconjunctivaastudyfrommozambique
‡A
Human papillomaviruses in intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva: a study from Mozambique
‡9
1
|
|
919
|
|
|
‡a
howtotreatasignalcurrentbasisforretgenotypeorientedchoiceofkinaseinhibitorsforthetreatmentofmedullarythyroidcancer
‡A
How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer
‡9
1
|
|
919
|
|
|
‡a
hobnailvariantofpapillarythyroidcarcinomaclinicopathologicandmolecularevidenceofprogressiontoundifferentiatedcarcinomain2cases
‡A
Hobnail Variant of Papillary Thyroid Carcinoma: Clinicopathologic and Molecular Evidence of Progression to Undifferentiated Carcinoma in 2 Cases.
‡9
1
|
|
919
|
|
|
‡a
highfrequencyofgermlinesuccinatedehydrogenasemutationsinsporadiccervicalparagangliomasinnorthernspainmitochondrialsuccinatedehydrogenasestructurefunctionrelationshipsandclinicalpathologicalcorrelations
‡A
High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations
‡9
1
|
|
919
|
|
|
‡a
headandnecklesionsinacohortirradiatedinchildhoodfortineacapitistreatment
‡A
Head and neck lesions in a cohort irradiated in childhood for tinea capitis treatment
‡9
1
|
|
919
|
|
|
‡a
hras81polymorphismissignificantlyassociatedwithaneuploidyinfolliculartumorsofthethyroid
‡A
H-RAS 81 polymorphism is significantly associated with aneuploidy in follicular tumors of the thyroid
‡9
1
|
|
919
|
|
|
‡a
grim19inhealthanddisease
‡A
GRIM-19 in Health and Disease.
‡9
1
|
|
919
|
|
|
‡a
glut1mct14andcd147overexpressionsupportsthemetabolicreprogramminginpapillaryrenalcellcarcinoma
‡A
GLUT1, MCT1/4 and CD147 overexpression supports the metabolic reprogramming in papillary renal cell carcinoma
‡9
1
|
|
919
|
|
|
‡a
germlinesuccinatedehydrogenasesubunit500mutationsegregatingwithfamilialnonret100cellhyperplasia
‡A
Germline succinate dehydrogenase subunit D mutation segregating with familial non-RET C cell hyperplasia.
‡9
1
|
|
919
|
|
|
‡a
genotypingrhdzygosityusingrealtimepolymerasechainreaction
‡A
Genotyping RHD zygosity using real-time polymerase chain reaction
‡9
1
|
|
919
|
|
|
‡a
geneticalterationsinthyroidtumorsfrompatientsirradiatedinchildhoodfortineacapitistreatment
‡A
Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment
‡9
1
|
|
919
|
|
|
‡a
geneticalterationsinpoorlydifferentiatedandundifferentiatedthyroidcarcinomas
‡A
Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas
‡9
1
|
|
919
|
|
|
‡a
gastriccarcinomaexhibitsdistincttypesofcelldifferentiationanimmunohistochemicalstudyoftrefoilpeptidestff1andtff2andmucinsmuc1muc2muc5acandmuc6
‡A
Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6)
‡9
1
|
|
919
|
|
|
‡a
frequencyoftertpromotermutationsinhumancancers
‡A
Frequency of TERT promoter mutations in human cancers
‡9
1
|
|
919
|
|
|
‡a
follicularthyroidcarcinomawithanunusualglomeruloidpatternofgrowth
‡A
Follicular thyroid carcinoma with an unusual glomeruloid pattern of growth
‡9
1
|
|
919
|
|
|
‡a
follicularthyroidcarcinoma
‡A
Follicular thyroid carcinoma
‡9
1
|
|
919
|
|
|
‡a
follicularpapillaryandhybridcarcinomasofthethyroid
‡A
Follicular, papillary, and "hybrid" carcinomas of the thyroid.
‡9
1
|
|
919
|
|
|
‡a
fetaladenomasandminimallyinvasivefollicularcarcinomasofthethyroidfrequentlydisplayatriploidorneartriploiddnapattern
‡A
Fetal adenomas and minimally invasive follicular carcinomas of the thyroid frequently display a triploid or near triploid DNA pattern
‡9
1
|
|
919
|
|
|
‡a
farewelltothedualhistogenesisofthyroidtumors
‡A
Farewell to the dual histogenesis of thyroid tumors?
‡9
1
|
|
919
|
|
|
‡a
expressionofsimplemucintypeantigensandlewistype1andtype2chainantigensinthethyroidglandanimmunohistochemicalstudyofnormalthyroidtissuesbenignlesionsandmalignanttumors
‡A
Expression of Simple Mucin Type Antigens and Lewis Type 1 and Type 2 Chain Antigens in the Thyroid Gland: An Immunohistochemical Study of Normal Thyroid Tissues, Benign Lesions, and Malignant Tumors
‡9
1
|
|
919
|
|
|
‡a
expressionofmucinsmuc1muc2muc5acandmuc6andtype1lewisantigensincaseswithandwithouthelicobacterpyloricolonizationinmetaplasticglandsofthehumanstomach
‡A
Expression of mucins (MUC1, MUC2, MUC5AC, and MUC6) and type 1 Lewis antigens in cases with and withoutHelicobacter pyloricolonization in metaplastic glands of the human stomach
‡9
1
|
|
919
|
|
|
‡a
expressionoflewisantigensinpapillarycarcinomaofthethyroidgland
‡A
Expression of Lewis antigens in papillary carcinoma of the thyroid gland
‡9
1
|
|
919
|
|
|
‡a
expressionof100erbb2intumoursandtumourlikelesionsofthethyroid
‡A
Expression of C-erb B2 in tumours and tumour-like lesions of the thyroid
‡9
1
|
|
919
|
|
|
‡a
ewsr1rearrangementisafrequenteventinpapillarythyroidcarcinomaandincarcinomaofthethyroidwithewingfamilytumorelementscefte
‡A
EWSR1 rearrangement is a frequent event in papillary thyroid carcinoma and in carcinoma of the thyroid with Ewing family tumor elements (CEFTE).
‡9
1
|
|
919
|
|
|
‡a
ewsr1rearrangementisafrequenteventinpapillarythyroidcarcinomaandincarcinomaofthethyroidwithewingfamilytumorelements
‡A
EWSR1 rearrangement is a frequent event in papillary thyroid carcinoma and in carcinoma of the thyroid with Ewing family tumor elements
‡9
1
|
|
919
|
|
|
‡a
europeanperspectiveon2015americanthyroidassociationmanagementguidelinesforadultpatientswiththyroidnodulesanddifferentiatedthyroidcancerproceedingsofaninteractiveinternationalsymposium
‡A
European Perspective on 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Proceedings of an Interactive International Symposium.
‡9
1
|
|
919
|
|
|
‡a
etiopathogenesisofoncocytomas
‡A
Etiopathogenesis of oncocytomas
‡9
1
|
|
919
|
|
|
‡a
epithelialdegenerationinducedbyhelicobacterpylori
‡A
Epithelial degeneration induced by Helicobacter pylori
‡9
1
|
|
919
|
|
|
‡a
endoscopicultrasonographicfeaturesofgastricmucosaassociatedlymphoidtissuelymphomawithapseudocircumvolutoryappearance
‡A
Endoscopic ultrasonographic features of gastric mucosa-associated lymphoid tissue lymphoma with a 'pseudocircumvolutory' appearance.
‡9
1
|
|
919
|
|
|
‡a
endocrinetumoursgeneticpredictorsofthyroidcanceroutcome
‡A
ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome
‡9
1
|
|
919
|
|
|
‡a
effectofmir128indnadamageofhl60acutemyeloidleukemiacells
‡A
Effect of miR-128 in DNA damage of HL-60 acute myeloid leukemia cells.
‡9
1
|
|
919
|
|
|
‡a
earlygastricstumpcarcinomawithrhabdoidfeatures
‡A
Early Gastric Stump Carcinoma with Rhabdoid Features
‡9
1
|
|
919
|
|
|
‡a
ecadherinmutationsingastriccarcinoma
‡A
E-cadherin mutations in gastric carcinoma
‡9
1
|
|
919
|
|
|
‡a
ecadherinlossratherthanbetacateninalterationsisacommonfeatureofpoorlydifferentiatedthyroidcarcinomas
‡A
E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas.
‡9
1
|
|
919
|
|
|
‡a
ecadheringenecdh1promotermethylationasthe2hitinsporadicdiffusegastriccarcinoma
‡A
E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma
‡9
1
|
|
919
|
|
|
‡a
ecadheringene
‡A
E-cadherin gene
‡9
1
|
|
919
|
|
|
‡a
ecadherinchangesingastriccarcimona
‡A
E-cadherin changes in gastric carcimona
‡9
1
|
|
919
|
|
|
‡a
dynaminrelatedprotein1atthecrossroadsofcancer
‡A
Dynamin-Related Protein 1 at the Crossroads of Cancer.
‡9
1
|
|
919
|
|
|
‡a
docathepsinsplayaroleinthebiologicalbehaviorofgastriccarcinoma
‡A
Do cathepsins play a role in the biological behavior of gastric carcinoma?
‡9
1
|
|
919
|
|
|
‡a
dimericsialylle10expressioningastriccarcinomacorrelateswithvenousinvasionandpooroutcome
‡A
Dimeric sialyl-Le(x) expression in gastric carcinoma correlates with venous invasion and poor outcome
‡9
1
|
|
919
|
|
|
‡a
dimericsialylle
‡A
Dimeric sialyl-Le
‡9
1
|
|
919
|
|
|
‡a
diffusesclerosingvariantofpapillarythyroidcarcinomaaclinicopathologicstudyof10cases
‡A
Diffuse sclerosing variant of papillary thyroid carcinoma. A clinicopathologic study of 10 cases
‡9
1
|
|
919
|
|
|
‡a
diffuseormultinodularfollicularvariantofpapillarythyroidcarcinomaaclinicopathologicandimmunohistochemicalanalysisof10casesofanaggressiveformofdifferentiatedthyroidcarcinoma
‡A
Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma: a clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma.
‡9
1
|
|
919
|
|
|
‡a
diffuse
‡A
Diffuse
‡9
1
|
|
919
|
|
|
‡a
difficultcasesofthyroidpathology
‡A
Difficult cases of thyroid pathology
‡9
1
|
|
919
|
|
|
‡a
differentiatedthyroidcancerinpatientswithresistancetothyroidhormonesyndromeanovelcaseandareviewoftheliterature
‡A
Differentiated thyroid cancer in patients with resistance to thyroid hormone syndrome. A novel case and a review of the literature.
‡9
1
|
|
919
|
|
|
‡a
differenttypesofepithelialcadherinalterationsplaydifferentrolesinhumancarcinogenesis
‡A
Different types of epithelial cadherin alterations play different roles in human carcinogenesis
‡9
1
|
|
919
|
|
|
‡a
differentpatternsofbetacateninexpressioningastriccarcinomasrelationshipwithclinicopathologicalparametersandprognosticoutcome
‡A
Different patterns of beta-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome
‡9
1
|
|
919
|
|
|
‡a
diagnosticandprognosticimplicationsofthepax8pparγtranslocationinthyroidcarcinomasatmabasedstudyof226cases
‡A
Diagnostic and prognostic implications of the PAX8-PPARγ translocation in thyroid carcinomas-a TMA-based study of 226 cases
‡9
1
|
|
919
|
|
|
‡a
cytogeneticfindingsin11gastriccarcinomas
‡A
Cytogenetic findings in eleven gastric carcinomas.
‡9
1
|
|
919
|
|
|
‡a
cystictumoroftheatrioventricularnodeoftheheartappearstobetheheartequivalentofthesolidcellnestsultimobranchialrestsofthethyroid
‡A
Cystic tumor of the atrioventricular node of the heart appears to be the heart equivalent of the solid cell nests (ultimobranchial rests) of the thyroid
‡9
1
|
|
919
|
|
|
‡a
currentthoughtsonthehistopathogenesisofgastriccancer
‡A
Current thoughts on the histopathogenesis of gastric cancer.
‡9
1
|
|
919
|
|
|
‡a
cribriformmorularvariantofpapillarythyroidcarcinomadisplayingpoorlydifferentiatedfeatures
‡A
Cribriform-Morular Variant of Papillary Thyroid Carcinoma Displaying Poorly Differentiated Features
‡9
1
|
|
919
|
|
|
‡a
cribriformmorularvariantofpapillarythyroidcarcinoma
‡A
Cribriform-Morular Variant of Papillary Thyroid Carcinoma
‡9
1
|
|
919
|
|
|
‡a
crabp1c1ql1andlcn2arebiomarkersofdifferentiatedthyroidcarcinomaandpredictextrathyroidalextension
‡A
CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension
‡9
1
|
|
919
|
|
|
‡a
core1geneisoverexpressedinhurthleandnonhurthlecellmicrofollicularadenomasandfollicularcarcinomasofthethyroid
‡A
Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid
‡9
1
|
|
919
|
|
|
‡a
concurrentproductionofcalcitoninandthyroglobulinbythesameneoplasticcells
‡A
Concurrent production of calcitonin and thyroglobulin by the same neoplastic cells
‡9
1
|
|
919
|
|
|
‡a
comparativemorphometricstudyofthecellsofthe3proximalsegmentoftheratkidneyunderdifferentconditionsoffixation
‡A
Comparative morphometric study of the cells of the third proximal segment of the rat kidney under different conditions of fixation
‡9
1
|
|
919
|
|
|
‡a
commentsonmutationsinmitochondrialcontrolregiondnaingastrictumoursofjapanesepatientstamuraetaleurjcancer199935316319
‡A
Comments on: Mutations in Mitochondrial Control Region DNA in Gastric Tumours of Japanese Patients, Tamura, et al. Eur J Cancer 1999, 35, 316–319
‡9
1
|
|
919
|
|
|
‡a
columnarcellcarcinomaanothervariantofpoorlydifferentiatedcarcinomaofthethyroid
‡A
Columnar-cell carcinoma. Another variant of poorly differentiated carcinoma of the thyroid
‡9
1
|
|
919
|
|
|
‡a
coexistenceoftertpromoterandbrafmutationsinpapillarythyroidcarcinomaaddedvalueinpatientprognosis
‡A
Coexistence of TERT promoter and BRAF mutations in papillary thyroid carcinoma: added value in patient prognosis?
‡9
1
|
|
919
|
|
|
‡a
chromosomalepigeneticandmicrornamediatedinactivationoflrp1bamodulatoroftheextracellularenvironmentofthyroidcancercells
‡A
Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells
‡9
1
|
|
919
|
|
|
‡a
cdx2expressioninsomevariantsofpapillarythyroidcarcinoma
‡A
CDX2 Expression in Some Variants of Papillary Thyroid Carcinoma
‡9
1
|
|
919
|
|
|
‡a
carcinomaofthethyroidwithewingpnetfamilytumorelementsatumorofunknownhistogenesis
‡A
Carcinoma of the thyroid with Ewing/PNET family tumor elements: a tumor of unknown histogenesis
‡9
1
|
|
919
|
|
|
‡a
carcinomaofthethyroidwithewingfamilytumorelementsandfavorableprognosisreportofa2case
‡A
Carcinoma of the thyroid with ewing family tumor elements and favorable prognosis: report of a second case
‡9
1
|
|
919
|
|
|
‡a
carcinomaarisingingastrichyperplasticpolyps
‡A
Carcinoma arising in gastric hyperplastic polyps
‡9
1
|
|
919
|
|
|
‡a
calcitoninreceptorexpressioninmedullarythyroidcarcinoma
‡A
Calcitonin receptor expression in medullary thyroid carcinoma
‡9
1
|
|
919
|
|
|
‡a
100cellhyperplasiaandpapillarythyroidcarcinoma
‡A
C-Cell Hyperplasia and Papillary Thyroid Carcinoma
‡9
1
|
|
919
|
|
|
‡a
100cellderivedcalcitoninfreeneuroendocrinecarcinomaofthethyroid
‡A
C-Cell-Derived Calcitonin-Free Neuroendocrine Carcinoma of the Thyroid
‡9
1
|
|
919
|
|
|
‡a
breasttumorresemblingthetallcellvariantofpapillarythyroidcarcinomaacasereport
‡A
Breast tumor resembling the tall cell variant of papillary thyroid carcinoma: a case report.
‡9
1
|
|
919
|
|
|
‡a
brafmutationsareassociatedwithsomehistologicaltypesofpapillarythyroidcarcinoma
‡A
BRAF mutations are associated with some histological types of papillary thyroid carcinoma
‡9
1
|
|
919
|
|
|
‡a
brafmutationsandretptcrearrangementsarealternativeeventsintheetiopathogenesisofptc
‡A
BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC
‡9
1
|
|
919
|
|
|
‡a
brafmutationinsolidcellnesthyperplasiaassociatedwithpapillarythyroidcarcinomaaprecursorlesion
‡A
BRAF mutation in solid cell nest hyperplasia associated with papillary thyroid carcinoma. A precursor lesion?
‡9
1
|
|
919
|
|
|
‡a
benignandmalignantthyroidlesionsshowinstabilityatmicrosatelliteloci
‡A
Benign and malignant thyroid lesions show instability at microsatellite loci
‡9
1
|
|
919
|
|
|
‡a
analysisof242casesofgastriccarcinoma
‡A
Analysis of 242 cases of gastric carcinoma
‡9
1
|
|
919
|
|
|
‡a
ultrastructuralmorphometricstudyofmossyfiberendingsinpigeonratandman
‡A
An ultrastructural morphometric study of mossy fiber endings in pigeon, rat and man
‡9
1
|
|
919
|
|
|
‡a
extraordinarycaseofmesenchymalchondrosarcomametastasisinthethyroid
‡A
An extraordinary case of mesenchymal chondrosarcoma metastasis in the thyroid.
‡9
1
|
|
919
|
|
|
‡a
acquisitionofbrafgenemutationsisnotarequirementfornodalmetastasisofpapillarythyroidcarcinoma
‡A
Acquisition of BRAF gene mutations is not a requirement for nodal metastasis of papillary thyroid carcinoma
‡9
1
|
|
919
|
|
|
‡a
accountingfortissueheterogeneityininfraredspectroscopicimagingforaccuratediagnosisofthyroidcarcinomasubtypes
‡A
Accounting for tissue heterogeneity in infrared spectroscopic imaging for accurate diagnosis of thyroid carcinoma subtypes
‡9
1
|
|
919
|
|
|
‡a
absenceofthebrafandthegrim19mutationsinoncocytichurthlecellsolidcellnestsofthethyroid
‡A
Absence of theBRAFand theGRIM-19Mutations in Oncocytic (Hürthle Cell) Solid Cell Nests of the Thyroid
‡9
1
|
|
919
|
|
|
‡a
absenceofthebrafandthegrim19mutationsinoncocytic
‡A
Absence of theBRAFand theGRIM-19Mutations in Oncocytic
‡9
1
|
|
919
|
|
|
‡a
abnormalitiesoftheecadherincateninadhesioncomplexinclassicalpapillarythyroidcarcinomaandinitsdiffusesclerosingvariant
‡A
Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant
‡9
1
|
|
919
|
|
|
‡a
subsetofthefollicularvariantofpapillarythyroidcarcinomaharborsthepax8ppargammatranslocation
‡A
A subset of the follicular variant of papillary thyroid carcinoma harbors the PAX8-PPARgamma translocation.
‡9
1
|
|
919
|
|
|
‡a
stemcellroleforthyroidsolidcellnests
‡A
A stem cell role for thyroid solid cell nests.
‡9
1
|
|
919
|
|
|
‡a
scanningandtransmissionelectronmicroscopicstudyofhumannodulargoitre
‡A
A scanning and transmission electron microscopic study of human nodular goitre
‡9
1
|
|
919
|
|
|
‡a
proinflammatorygeneticprofileincreasestheriskforchronicatrophicgastritisandgastriccarcinoma
‡A
A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma
‡9
1
|
|
919
|
|
|
‡a
polymorphisminthepromoterregionoftheselenoproteinsgeneseps1contributestohashimotosthyroiditissusceptibility
‡A
A Polymorphism in the Promoter Region of the Selenoprotein S Gene (SEPS1) Contributes to Hashimoto's Thyroiditis Susceptibility
‡9
1
|
|
919
|
|
|
‡a
polymorphisminthepromoterregionoftheselenoproteinsgene
‡A
A Polymorphism in the Promoter Region of the Selenoprotein S Gene
‡9
1
|
|
919
|
|
|
‡a
newbrafgenemutationdetectedinacaseofasolidvariantofpapillarythyroidcarcinoma
‡A
A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma
‡9
1
|
|
919
|
|
|
‡a
mucinproducingtumorinthethyroidgland
‡A
A mucin-producing tumor in the thyroid gland
‡9
1
|
|
919
|
|
|
‡a
morphometricstudyofnucleinucleoliandnuclearbodiesingoitresandpapillarythyroidcarcinomas
‡A
A morphometric study of nuclei, nucleoli and nuclear bodies in goitres and papillary thyroid carcinomas
‡9
1
|
|
919
|
|
|
‡a
foundersdhbmutationinportugueseparagangliomapatients
‡A
A founder SDHB mutation in Portuguese paraganglioma patients
‡9
1
|
|
919
|
|
|
‡a
follicularvariantofpapillarythyroidcarcinomainstrumaovariicasereportwithuniquemolecularalterations
‡A
A follicular variant of papillary thyroid carcinoma in struma ovarii. Case report with unique molecular alterations.
‡9
1
|
|
919
|
|
|
‡a
flowcytometricdnaanalysisofmedullarythyroidcarcinoma
‡A
A flow cytometric DNA analysis of medullary thyroid carcinoma
‡9
1
|
|
919
|
|
|
‡a
replytolowprevalenceofbrafmutationsinradiationinducedthyroidtumorsincontrasttosporadicpapillarycarcinomas
‡A
Reply to: Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas
‡9
1
|
|
919
|
|
|
‡a
recentadvancesincytometrycytogeneticsandmoleculargeneticsofthyroidtumoursandtumourlikelesions
‡A
Recent advances in cytometry, cytogenetics and molecular genetics of thyroid tumours and tumour-like lesions.
‡9
1
|
|
919
|
|
|
‡a
replytothenewmolecularmarkersddit3stt3aarg2andfam129aarenotusefulindiagnosingthyroidfolliculartumors
‡A
Reply to 'The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors'
‡9
1
|
|
943
|
|
|
‡a
196x
‡A
1963
‡9
1
|
|
946
|
|
|
‡a
b
‡9
1
|
|
947
|
|
|
‡a
PT
‡9
1
|
|
993
|
|
|
‡a
Sobrino-Simones, Manuel.
‡t
Exercises in ultrastructural pathology
‡2
XR|VIAFWORK20823920
‡3
worktoname
|
|
993
|
|
|
‡a
Sobrino-Simones, Manuel.
‡t
Exercises in ultrastructural pathology
‡l
Japanese
‡f
1995
‡2
XR|VIAFEXP674841165
‡3
exprtoname
|
|
996
|
|
|
‡2
PTBNP|251582
|
|
996
|
|
|
‡2
ISNI|0000000117555529
|
|
996
|
|
|
‡2
LC|n 82031517
|
|
996
|
|
|
‡2
NII|DA04849325
|
|
996
|
|
|
‡2
RERO|A003834436
|
|
996
|
|
|
‡2
LC|n 84119590
|
|
996
|
|
|
‡2
PTBNP|104929
|
|
996
|
|
|
‡2
DNB|1068536195
|
|
996
|
|
|
‡2
ISNI|0000000070927742
|
|
996
|
|
|
‡2
BNC|981061102532406706
|
|
996
|
|
|
‡2
PTBNP|1768146
|
|
996
|
|
|
‡2
NDL|00516307
|
|
996
|
|
|
‡2
DNB|12718970X
|
|
996
|
|
|
‡2
PTBNP|94221
|
|
996
|
|
|
‡2
ISNI|0000000067324801
|
|
996
|
|
|
‡2
SUDOC|273366483
|
|
996
|
|
|
‡2
PTBNP|286970
|
|
996
|
|
|
‡2
PTBNP|1600418
|
|
996
|
|
|
‡2
ISNI|0000000069593941
|
|
996
|
|
|
‡2
BLBNB|000568157
|
|
996
|
|
|
‡2
ISNI|0000000070437508
|
|
996
|
|
|
‡2
NUKAT|n 2010107722
|
|
996
|
|
|
‡2
PTBNP|1855751
|
|
996
|
|
|
‡2
BNE|XX1421108
|
|
996
|
|
|
‡2
CAOONL|ncf11948761
|
|
996
|
|
|
‡2
PTBNP|1567736
|
|
996
|
|
|
‡2
ISNI|0000000068678687
|
|
996
|
|
|
‡2
PTBNP|283551
|
|
996
|
|
|
‡2
PTBNP|283938
|
|
996
|
|
|
‡2
BIBSYS|5100453
|
|
996
|
|
|
‡2
PTBNP|228442
|
|
996
|
|
|
‡2
LC|n 88191411
|
|
996
|
|
|
‡2
RERO|A003834435
|
|
996
|
|
|
‡2
ISNI|000000007082994X
|
|
996
|
|
|
‡2
NII|DA13854494
|
|
996
|
|
|
‡2
PTBNP|1877982
|
|
996
|
|
|
‡2
PTBNP|284913
|
|
997
|
|
|
‡a
1947 0 lived 0908 0
‡9
1
|
|
998
|
|
|
‡a
Sobrinho-Simões, Manuel.
‡2
NUKAT|n 2010107722
‡3
viafid
|
|
998
|
|
|
‡a
Sobrinho Simões, Manuel,
‡2
SUDOC|162008376
‡3
suggested
‡3
partial date, partial title
|
|
998
|
|
|
‡a
Sobrinho-Simões, Manuel
‡2
J9U|987007393779105171
‡3
partial date, partial title
‡3
viafid
|
|
998
|
|
|
‡a
Sobrinho-Simões, Manuel
‡2
NII|DA04849325
‡3
suggested
|
|
998
|
|
|
‡a
Sobrinho Simões, Manuel
‡2
DNB|1177399466
‡3
suggested
‡3
standard number
|
|
998
|
|
|
‡a
Sobrinho Simões, Manuel
‡2
SZ|1177399466
‡3
standard number
|
|
998
|
|
|
‡a
Simões, Manuel Sobrinho
‡2
ISNI|0000000068678687
‡3
suggested
|
|
998
|
|
|
‡a
Sobrinho Simões, Manuel
‡2
ISNI|0000000068678687
‡3
suggested
|
|
998
|
|
|
‡a
Manuel Sobrinho Simões
‡2
ISNI|0000000068678687
‡3
suggested
|
|
998
|
|
|
‡a
Sobrinho Simões, Manuel
‡2
ISNI|0000000068678687
‡3
suggested
|
|
998
|
|
|
‡a
Simões,
‡b
Manuel Areias Sobrinho
‡2
PTBNP|1208576
‡3
title: (0.98, 'insearchoforiginalleukemiccloneinchronicmyeloidleukemiapatientsincompletemolecularremissionafterstemcelltransplantationorimatinib', 'insearchoftheoriginalleukemiccloneinchronicmyeloidleukemiapatientsincompletemolecularremissionafterstemcelltransplantationorimatinib')
|
|
998
|
|
|
‡a
Simões,
‡b
Manuel Sobrinho,
‡2
PTBNP|1056572
‡3
suggested
‡3
title: (0.82, 'papilarythyroidcarcinoma', 'rarepapillarythyroidcarcinomas')
|
